Academic Appointment
Academic Coordinator for MSc in Biomaterials for Functional tissue Reconstruction
Research focus
Developing culture systems for disease modelling and translational research that incorporate biomaterials for functional tissue reconstruction, my work focuses on biocompatibility and the optimisation of structured and hydrogel-based scaffolds to recapitulate cell–matrix interactions, guide stem-cell differentiation in 3D culture systems, and sustain tissue development.
Research in Context
My research integrates the use of biomaterials as scaffolds or tissue-delivery systems with advanced fabrication strategies, adopting a systems tissue engineering perspective to evaluate material–cell interactions and functional integration. Omics-enabled databases and translational approaches are employed to advance understanding of cell adhesion and differentiation, and to assess the translational value of in vitro models for tissue development and regeneration.
Current work develops and applies omics and advanced bioimaging approaches to investigate developmental processes and congenital anomalies, with a growing focus on perinatal stem cell–derived 3D models for maternal and reproductive health. I am involved in EU and national collaborations exploring developmental and neurobiological processes, including differentiation and the bone–brain axis.
My work is anchored by an affiliation with the Karolinska Institutet, Department of Women’s and Children’s Health, contributing to international collaborations in developmental biology and women’s health research.
Research Highlights
- Bioengineering & 3D cell models: Our studies investigate how aligned and random nanofiber architectures regulate neural growth and 3D cell organization, alongside protocols for reusable 3D culture platforms, models of oral inflammation under hypoxic conditions, and the evaluation of engineered nanofibres for tissue reconstruction.
- Biocompatibility & future frameworks: Perspective work advances biocompatibility assessment, addressing regulatory, biological, and AI-driven challenges.
- Clinical evidence synthesis: Landmark systematic review and meta-analysis on The Lancet Obstetrics, Gynaecology and Women's health shows no clinically important increase in the likelihood of autism spectrum disorder, ADHD, or intellectual disability following prenatal paracetamol use as directed.